Not applicableStudy completedNCT00633945
What this trial is testing
Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)
Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
University of Pennsylvania 5